At a time when state Medicaid budgets are under increasing pressure, UMass Medical School is saving hundreds of millions of dollars for states across the country through its third party liability work.
The Massachusetts Pharmacists Association (MPhA) bestows UMass Medical School pharmacy leader Kimberly Lenz, PharmD, with the Cardinal Health Generation Rx Champions Award Sept. 14 for her efforts to combat prescription drug abuse.
For state Medicaid programs and other health plans, keeping up with the dramatic progress in new Hepatitis C drugs and treatment can be a major challenge, says UMass Medical School pharmacist Pavel Lavitas, PharmD, BCPS.
An effective opioid management program requires a delicate balance between prevention of abuse while also ensuring that patients who legitimately need pain medication have access, says UMass Medical School expert.
Experts from UMass Medical School said managed care plans can use a variety of tools to combat the opioid crisis, including a therapeutic class management team, according to an article in Pharmacy Practice News.
UMass Medical School’s TrendFinder LTSS data analytics platform helps state agencies and private health plans meet growing demand for home care and other long-term services and supports amid lean budgets.
UMass Medical School’s long-term services and supports (LTSS) solutions will be both celebrated and presented at the National Home and Community Based Services (HCBS) Conference in Baltimore, Maryland, Aug. 27-31.
Utilizing evidence-based practices, being able to constantly monitor the latest research and being nimble are the key components of a successful opioid management program, says Tyson Thompson, PharmD.
UMass Medical School experts will present on increasing third party liability savings in Medicaid programs and standardizing the procurement process at the annual Medicaid Enterprise Systems Conference on August 15-18.
The University of Massachusetts Medical School’s Commonwealth Medicine division (UMass) is pleased to announce its strategic partnership with Long Term Care Innovation, Inc. (LTCI) based in Burlington, Vermont.
Medication assisted treatment has proven to be powerful weapon in communities across the country in efforts to stem the tide of the opioid epidemic. Now, UMass Medical School’s Warren J. Ferguson, MD, is studying how jails and prisons can implement that model, according to a report by STAT.
UMass Medical School experts will present the historical evolution of services and supports for people with disabilities that led to the development of a Preadmission Screening Resident Review (PASRR) during a keynote on the first day of the 2017 PASRR Services in Texas Conference Aug. 9-10.
UMass Medical School will highlight the capabilities of its TrendFinder LTSS data analytics platform at the Mediware conference August 7-9 in New Orleans.
To ensure the right decision is made for individuals going through a disability determination, benefits agencies and organizations should utilize medical professionals and specialists to achieve well-informed conclusions, according to a UMass Medical School disability evaluation expert.
Hepatitis C is one of the top public health challenges facing the U.S., with as many as three to four million people currently living with this “chronic infection,” notes Pavel Lavitas, PharmD, BCPS, of UMass Medical School.